Attitudes, Beliefs and Willingness to Prescribe Medical Cannabis Among Public Medical Practitioners in Malaysia
| Journal | The Medical journal of Malaysia |
| Study Type | Clinical Study |
| Population | Human participants |
This Malaysian survey provides crucial insight into physician attitudes in a region where cannabis remains strictly prohibited recreationally, yet medical interest is emerging. Understanding practitioner willingness and knowledge gaps is essential as Southeast Asian countries consider medical cannabis frameworks.
This nationwide survey of 420 Malaysian government medical practitioners used a 23-item questionnaire to assess attitudes toward medical cannabis prescribing. Despite recreational prohibition, 65% agreed medical cannabis should be available for certain conditions, with pain management showing highest acceptance (87% generally, 74.3% specifically for cancer pain). The study captured perspectives across clinical specialties and employment levels, providing baseline data on knowledge exposure and prescribing willingness in a restrictive legal environment.
“What strikes me is the remarkably high acceptance rate for pain management despite the restrictive legal context – this mirrors patterns I’ve seen globally where clinical need often precedes policy reform. The specificity around cancer pain suggests practitioners are distinguishing between different pain contexts based on perceived legitimacy.”
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
FAQ
What is the overall attitude of Malaysian physicians toward medical cannabis?
According to this nationwide survey of 420 public medical practitioners in Malaysia, 65% agreed that medical cannabis should be available for certain medical conditions. This suggests a majority of physicians view medical cannabis as having legitimate therapeutic applications, despite recreational cannabis being illegal under Malaysian law.
Which medical conditions do Malaysian doctors most support treating with medical cannabis?
Pain management emerged as the primary indication, with 87% of surveyed physicians supporting medical cannabis for pain conditions. Additionally, 74.3% were willing to recommend medical cannabis specifically for cancer-related pain, indicating strong support for oncology applications.
How does physician knowledge affect willingness to prescribe medical cannabis?
While the study collected data on practitioners’ exposure to medical cannabis knowledge, the summary suggests that education and familiarity with evidence-based applications influences prescribing willingness. The high support rates for well-established indications like cancer pain reflect confidence in areas with stronger clinical evidence.
What are the main barriers to medical cannabis acceptance among Malaysian physicians?
Though 65% support medical cannabis availability, 35% remain opposed, likely reflecting concerns about legal frameworks, lack of standardized dosing guidelines, and limited clinical training. The study’s focus on case vignettes suggests physicians are more comfortable with specific, evidence-based scenarios than general cannabis prescribing.
How might these findings influence Malaysian medical cannabis policy?
The substantial physician support (65% overall, 87% for pain) provides evidence that could inform policy development in Malaysia. This data suggests the medical community is ready to engage with regulated medical cannabis programs, particularly for well-established indications like cancer pain management.
